These Analysts Slash Their Forecasts On C3.ai Following Q1 Results

C3.ai (AI) reported a significant first-quarter financial miss, with revenue of $70.26 million falling short of analyst estimates of $94.58 million and an adjusted loss of 37 cents per share, wider than the anticipated 20-cent loss. Following the announcement, the company's shares declined 4.2%. Chairman Thomas Siebel acknowledged the "unacceptable" performance, noting a sales and services organizational restructuring and a new CEO appointment, while several analysts, including Keybanc, JMP Securities, and UBS, subsequently lowered their price targets on the stock.

Analysis

C3.ai reported a significant first-quarter performance failure, with revenue of $70.26 million substantially missing analyst estimates of $94.58 million. The bottom line was similarly weak, posting an adjusted loss of 37 cents per share, nearly double the consensus estimate for a 20-cent loss. Chairman Thomas Siebel labeled the financial results as "completely unacceptable," signaling the severity of the operational shortfalls. In response, the company has undertaken a complete restructuring of its sales and services organization, including new leadership, and has appointed a new CEO to steer a turnaround. The market reacted negatively to the news, with C3.ai shares falling 4.2% to $15.98. This sentiment was echoed by sell-side analysts who broadly lowered their price targets; Keybanc reiterated an Underweight rating while cutting its target to $10, UBS maintained a Neutral stance with a new $16 target, and JMP Securities, while maintaining a Market Outperform rating, still reduced its target from $30 to $24, reflecting a widespread recalibration of expectations despite differing long-term outlooks.

Key Decisions for Investors

• Investors should recognize the significant execution risk highlighted by the severe Q1 earnings miss and the complete overhaul of the sales organization, suggesting near-term uncertainty and performance volatility will remain high.
• The appointment of a new CEO and the strategic restructuring present a potential turnaround catalyst, but it is prudent to await tangible evidence of improved execution in subsequent quarters before initiating or adding to positions.
• Given the wide dispersion in analyst price targets, ranging from $10 to $24, the current stock price of $15.98 reflects a market with no clear consensus, warranting a careful re-evaluation of valuation and risk-reward profile for any existing or potential investment.